EarningsQ2 2023 Earnings Report

Lakefront Biotherapeutics NV (GLPGN) Q2 2023 Earnings Report

― Followers

MX:GLPGN Q2 2023 EPS Results

Actual EPS$1.61

Consensus EPS-$15.02

Beat/MissBeat by +$16.63

One Year Ago EPS-$5.84

Actual Revenue$3.02B

Expected Revenue$2.16B

Beat/MissBeat by +$861.07M

YoY Revenue Growth+8.97%

QuarterQ2 2023

Date08/03/2023

TimeAfter Close

Conference CallThursday, August 3, 2023

MX:GLPGN Upcoming Earnings

Lakefront Biotherapeutics NV's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 12, 2026	2026 (Q3)	-14.46 / -	-61.814	―
Aug 10, 2026	2026 (Q2)	-14.09 / 0.60	-31.813	101.90% (+32.42)
May 06, 2026	2026 (Q1)	-16.41 / 4.23	-47.317	108.94% (+51.55)
Feb 23, 2026	2025 (Q4)	-2.21 / 239.00	5.819	4007.27% (+233.18)
Nov 05, 2025	2025 (Q3)	-8.26 / -61.81	-14.9	-314.86% (-46.91)
Jul 23, 2025	2025 (Q2)	-4.01 / -31.81	1.409	-2357.14% (-33.22)
Apr 23, 2025	2025 (Q1)	-2.74 / -47.32	7.249	-752.78% (-54.57)
Feb 12, 2025	2024 (Q4)	-10.29 / 5.82	48.122	-87.91% (-42.30)
Oct 30, 2024	2024 (Q3)	-3.12 / -14.90	7.853	-289.74% (-22.75)
Aug 01, 2024	2024 (Q2)	-1.37 / 1.41	1.611	-12.50% (-0.20)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed